The Thyroid

Brook's Clinical Pediatric Endocrinology: Sixth Edition

Volumn , Issue , 2010, Pages 250-282

  Brown, Rosalind S ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chronic lymphocytic thyroiditis; Congenital hypothyroidism (CH) common treatable cause of mental retardation; Non toxic (colloid) goiter and euthyroid thyroid enlargement in childhood; Radioactive iodine for patients having failed drug therapy; Thyroid; Thyroid hormonogenesis; Thyroid peroxidase (TPO); Thyrotoxic periodic paralysis (TPP) sudden weakness, hypokalemia and hyperthyroidism; Thyrotropin (TSH) major regulator of thyroid function; Thyroxine binding globulin (TBG)

Indexed keywords

EID: 84886056000     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444316728.ch12     Document Type: Chapter

References (99)

1. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, et al. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 1997; 17: 411-422.
2. Moreno JC, Bikker H, Kempers MJ, van Trotsenburg AS, Baas F, de Vijlder JJ, et al. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med 2002; 347: 95-102.
3. Vassart G, Dumont JE. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev 1992; 13: 596-611.
4. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J, Vassart G. Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab 1995; 80: 2577-2785.
5. Williams FL, Visser TJ, Hume R. Transient hypothyroxinaemia in preterm infants. Early Hum Dev 2006; 82: 797-802.
6. Eng PH, Cardona GR, Fang SL, Previti M, Alex S, Carrasco N, et al. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 1999; 140: 3404-3410.
7. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002; 23: 38-89.
8. Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP, Visser TJ. Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev 2001; 22: 451-476.
9. Brent GA. The molecular basis of thyroid hormone action. N Engl J Med 1994; 331: 847-853.
10. O'Shea PJ, Williams GR. Insight into the physiological actions of thyroid hormone receptors from genetically modified mice. J Endocrinol 2002; 175: 553-570.
11. Bernal J. Action of thyroid hormone in brain. J Endocrinol Invest 2002; 25: 268-288.
12. De Felice M, Di Lauro R. Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev 2004; 25: 722-746.
13. Fagman H, Grande M, Edsbagge J, Semb H, Nilsson M. Expression of classical cadherins in thyroid development: maintenance of an epithelial phenotype throughout organogenesis. Endocrinology 2003; 144: 3618-3624.
14. Fagman H, Liao J, Westerlund J, Andersson L, Morrow BE, Nilsson M. The 22q11 deletion syndrome candidate gene Tbx1 determines thyroid size and positioning. Hum Mol Genet 2007; 16: 276-285.
15. Fagman H, Grande M, Gritli-Linde A, Nilsson M. Genetic deletion of sonic hedgehog causes hemiagenesis and ectopic development of the thyroid in mouse. Am J Pathol 2004; 164: 1865-1872.
16. Brown RS, Shalhoub V, Coulter S, Alex S, Joris I, De Vito W, et al. Developmental regulation of thyrotropin receptor gene expression in the fetal and neonatal rat thyroid: relation to thyroid morphology and to thyroid-specific gene expression. Endocrinology 2000; 141: 340-5.
17. Stein SA, Shanklin DR, Krulich L, Roth MG, Chubb CM, Adams PM. Evaluation and characterization of the hyt/hyt hypothyroid mouse. II. Abnormalities of TSH and the thyroid gland. Neuroendocrinology 1989; 49: 509-519.
18. Campos-Barros A, Amma LL, Faris JS, Shailam R, Kelley MW, Forrest D. Type 2 iodothyronine deiodinase expression in the cochlea before the onset of hearing. Proc Natl Acad Sci U S A 2000; 97: 1287-1292.
19. Bernal J, Guadano-Ferraz A, Morte B. Perspectives in the study of thyroid hormone action on brain development and function. Thyroid 2003; 13: 1005-1012.
20. Anderson GW, Schoonover CM, Jones SA. Control of thyroid hormone action in the developing rat brain. Thyroid 2003; 13: 1039-1056.
21. Farwell AP, Dubord-Tomasetti SA. Thyroid hormone regulates the expression of laminin in the developing rat cerebellum. Endocrinology 1999; 140: 4221-4227.
22. Robson H, Siebler T, Stevens DA, Shalet SM, Williams GR. Thyroid hormone acts directly on growth plate chondrocytes to promote hypertrophic differentiation and inhibit clonal expansion and cell proliferation. Endocrinology 2000; 141: 3887-3897.
23. Robson H, Siebler T, Shalet SM, Williams GR. Interactions between GH, IGF-I, glucocorticoids and thyroid hormones during skeletal growth. Pediatr Res 2002; 52: 137-147.
24. Ball SG, Ikeda M, Chin WW. Deletion of the thyroid hormone beta1 receptor increases basal and triiodothyronine-induced growth hormone messenger ribonucleic acid in GH3 cells. Endocrinology 1997; 138: 3125-3132.
25. O'Shea PJ, Harvey CB, Suzuki H, Kaneshige M, Kaneshige K, Cheng SY, et al. A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormone. Mol Endocrinol 2003; 17: 1410-1424.
26. Akita S, Nakamura T, Hirano A, Fujii T, Yamashita S. Thyroid hormone action on rat calvarial sutures. Thyroid 1994; 4: 99-106.
27. Roti E, Gnudi A, Braverman LE. The placental transport, synthesis and metabolism of hormones and drugs which affect thyroid function. Endocr Rev 1983; 4: 131-149.
28. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 2000; 85: 3975-3987.
29. Cao XY, Jiang XM, Dou ZH, Rakeman MA, Zhang ML, O'Donnell K, et al. Timing of vulnerability of the brain to iodine deficiency in endemic cretinism. N Engl J Med 1994; 331: 1739-1744.
30. de Zegher F, Pernasetti F, Vanhole C, Devlieger H, Van den Berghe G, Martial JA. The prenatal role of thyroid hormone evidenced by fetomaternal Pit-1 deficiency. J Clin Endocrinol Metab 1995; 80: 3127-3130.
31. Matsuura N, Konishi J. Transient hypothyroidism in infants born to mothers with chronic thyroiditis: a nationwide study of twenty-three cases. The Transient Hypothyroidism Study Group. Endocrinol Jpn 1990; 37: 369-379.
32. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341: 549-555.
33. Pop VJ, Kuijpens JL, van Baar AL, Verkerk G, van Son MM, de Vijlder JJ, et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf) 1999; 50: 149-155.
34. Thorpe-Beeston JG, Nicolaides KH, McGregor AM. Fetal thyroid function. Thyroid 1992; 2: 207-217.
35. Mercado M, Yu VY, Francis I, Szymonowicz W, Gold H. Thyroid function in very preterm infants. Early Hum Dev 1988; 16: 131-141.
36. Williams FL, Simpson J, Delahunty C, Ogston SA, Bongers-Schokking JJ, Murphy N, et al. Developmental trends in cord and postpartum serum thyroid hormones in preterm infants. J Clin Endocrinol Metab 2004; 89: 5314-5320.
37. Deming DD, Rabin CW, Hopper AO, Peverini RL, Vyhmeister NR, Nelson JC. Direct equilibrium dialysis compared with two non-dialysis free T4 methods in premature infants. J Pediatr 2007; 151: 404-408.
38. Ares S, Escobar-Morreale HF, Quero J, Duran S, Presas MJ, Herruzo R, et al. Neonatal hypothyroxinemia: effects of iodine intake and premature birth. J Clin Endocrinol Metab 1997; 82: 1704-1712.
39. Frank JE, Faix JE, Hermos RJ, Mullaney DM, Rojan DA, Mitchell ML, et al. Thyroid function in very low birth weight infants: effects on neonatal hypothyroidism screening. J Pediatr 1996; 128: 548-554.
40. Zurakowski D, Di Canzio J, Majzoub JA. Pediatric reference intervals for serum thyroxine, triiodothyronine, thyrotropin and free thyroxine. Clin Chem 1999; 45: 1087-1091.
41. Delange FM. Iodine Deficiency. In: Braverman LE, Utiger RD, eds. Werner & Ingbar's The Thyroid, 8th edn. Philadelphia: Lippincott Williams & Wilkins; 2000.
42. Boyages SC. Clinical review 49: iodine deficiency disorders. J Clin Endocrinol Metab 1993; 77: 587-591.
43. Lanting CI, van Tijn DA, Loeber JG, Vulsma T, de Vijlder JJ, Verkerk PH. Clinical effectiveness and cost-effectiveness of the use of the thyroxine/thyroxine-binding globulin ratio to detect congenital hypothyroidism of thyroidal and central origin in a neonatal screening program. Pediatrics 2005; 116: 168-173.
44. Fisher D. Next generation newborn screening for congenital hypothyroidism? J Clin Endocrinol Metab 2005; 90: 3797-3799.
45. van Tijn DA, de Vijlder JJ, Verbeeten B Jr, Verkerk PH, Vulsma T. Neonatal detection of congenital hypothyroidism of central origin. J Clin Endocrinol Metab 2005; 90: 3350-3359.
46. Harris KB, Pass KA. Increase in congenital hypothyroidism in New York State and in the United States. Mol Genet Metab 2007; 91: 268-277.
47. Kempers MJ, Lanting CI, van Heijst AF, van Trotsenburg AS, Wiedijk BM, de Vijlder JJ, et al. Neonatal screening for congenital hypothyroidism based on thyroxine, thyrotropin and thyroxine-binding globulin measurement: potentials and pitfalls. J Clin Endocrinol Metab 2006; 91: 3370-3376.
48. Hunter MK, Mandel SH, Sesser DE, Miyabira RS, Rien L, Skeels MR, et al. Follow-up of newborns with low thyroxine and non-elevated thyroid-stimulating hormone-screening concentrations: results of the 20-year experience in the Northwest Regional Newborn Screening Program. J Pediatr 1998; 132: 70-74.
49. Larson C, Hermos R, Delaney A, Daley D, Mitchell M. Risk factors associated with delayed thyrotropin elevations in congenital hypothyroidism. J Pediatr 2003; 143: 587-591.
50. Perry R, Heinrichs C, Bourdoux P, Khoury K, Szots F, Dussault JH, et al. Discordance of monozygotic twins for thyroid dysgenesis: implications for screening and for molecular pathophysiology. J Clin Endocrinol Metab 2002; 87: 4072-4077.
51. Adams LM, Emery JR, Clark SJ, Carlton EI, Nelson JC. Reference ranges for newer thyroid function tests in premature infants. J Pediatr 1995; 126: 122-127.
52. Brown RS, Demmer LA. The etiology of thyroid dysgenesis: still an enigma after all these years. J Clin Endocrinol Metab 2002; 87: 4069-4071.
53. Kopp P. Pendred's syndrome: identification of the genetic defect a century after its recognition. Thyroid 1999; 9: 65-69.
54. Gillam MP, Kopp P. Genetic defects in thyroid hormone synthesis. Curr Opin Pediatr 2001; 13: 364-372.
55. Moreno JC, Klootwijk W, van Toor H, Pinto G, D'Alessandro M, Leger A, et al. Mutations in the iodotyrosine deiodinase gene and hypothyroidism. N Engl J Med 2008; 358: 1811-1818.
56. Jordan N, Williams N, Gregory JW, Evans C, Owen M, Ludgate M. The W546X mutation of the thyrotropin receptor gene: potential major contributor to thyroid dysfunction in a Caucasian population. J Clin Endocrinol Metab 2003; 88: 1002-1005.
57. Djemli A, Van Vliet G, Delvin EE. Congenital hypothyroidism: from paracelsus to molecular diagnosis. Clin Biochem 2006; 39: 511-518.
58. Dumitrescu AM, Liao XH, Best TB, Brockmann K, Refetoff S. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 2004; 74: 168-175.
59. Dumitrescu AM, Liao XH, Abdullah MS, Lado-Abeal J, Majed FA, Moeller LC, et al. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet 2005; 37: 1247-1252.
60. Brown RS, Bloomfield S, Bednarek FJ, Mitchell ML, Braverman LE. Routine skin cleansing with povidone-iodine is not a common cause of transient neonatal hypothyroidism in North America: a prospective controlled study. Thyroid 1997; 7: 395-400.
61. Brown RS, Bellisario RL, Botero D, Fournier L, Abrams CA, Cowger ML, et al. Incidence of transient congenital hypothyroidism due to maternal thyrotropin receptor-blocking antibodies in over one million babies. J Clin Endocrinol Metab 1996; 81: 1147-1151.
62. Daliva AL, Linder B, DiMartino-Nardi J, Saenger P. Three-year follow-up of borderline congenital hypothyroidism. J Pediatr 2000; 136: 53-56.
63. Calaciura F, Motta RM, Miscio G, Fichera G, Leonardi D, Carta A, et al. Subclinical hypothyroidism in early childhood: a frequent outcome of transient neonatal hyperthyrotropinemia. J Clin Endocrinol Metab 2002; 87: 3209-3214.
64. Ohnishi H, Sato H, Noda H, Inomata H, Sasaki N. Color Doppler ultrasonography: diagnosis of ectopic thyroid gland in patients with congenital hypothyroidism caused by thyroid dysgenesis. J Clin Endocrinol Metab 2003; 88: 5145-5149.
65. Tiosano D, Even L, Shen Orr Z, Hochberg Z. Recombinant thyrotropin in the diagnosis of congenital hypothyroidism. J Clin Endocrinol Metab 2007; 92: 1434-1437.
66. Gruters A, Finke R, Krude H, Meinhold H. Etiological grouping of permanent congenital hypothyroidism with a thyroid gland in situ. Horm Res 1994; 41: 3-9.
67. Mehta A, Hindmarsh PC, Stanhope RG, Brain CE, Preece MA, Dattani MT. Is the thyrotropin-releasing hormone test necessary in the diagnosis of central hypothyroidism in children. J Clin Endocrinol Metab 2003; 88: 5696-5703.
68. Selva KA, Mandel SH, Rien L, Sesser D, Miyahira R, Skeels M, et al. Initial treatment dose of L-thyroxine in congenital hypothyroidism. J Pediatr 2002; 141: 786-792.
69. van Wassenaer AG, Kok JH, de Vijlder JJ, Briet JM, Smit BJ, Tamminga P, et al. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks'gestation. N Engl J Med 1997; 336: 21-26.
70. van Wassenaer AG, Westera J, Houtzager BA, Kok JH. Ten-year follow-up of children born at <30 weeks'gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial. Pediatrics 2005; 116: e613-618.
71. Selva KA, Harper A, Downs A, Blasco PA, Lafranchi SH. Neurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH. J Pediatr 2005; 147: 775-780.
72. Bongers-Schokking JJ, Koot HM, Wiersma D, Verkerk PH, de Muinck Keizer-Schrama SM. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr 2000; 136: 292-297.
73. Rovet JF. In search of the optimal therapy for congenital hypothyroidism. J Pediatr 2004; 144: 698-700.
74. Cassio A, Cacciari E, Cicognani A, Damiani G, Missiroli G, Corbelli E, et al. Treatment for congenital hypothyroidism: thyroxine alone or thyroxine plus triiodothyronine? Pediatrics 2003; 111 (5 Pt 1): 1055-1060.
75. Mitsuda N, Tamaki H, Amino N, Hosono T, Miyai K, Tanizawa O. Risk factors for developmental disorders in infants born to women with Graves disease. Obstet Gynecol 1992; 80 (3 Pt 1): 359-364.
76. Vaidya B, Kendall-Taylor P, Pearce SH. The genetics of autoimmune thyroid disease. J Clin Endocrinol Metab 2002; 87: 5385-5397.
77. Chinnery PF, Turnbull DM. Mitochondrial medicine. Q J Med 1997; 90: 657-667.
78. Huang SA, Tu HM, Harney JW, Venihaki M butte AJ, Kozakewich HP, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 2000; 343: 185-189.
79. Danese D, Sciacchitano S, Farsetti A andreoli M, Pontecorvi A. Diagnostic accuracy of conventional versus sonography-guided fineneedle aspiration biopsy of thyroid nodules. Thyroid 1998; 8: 15-21.
80. Cooper DS. Antithyroid drugs in the management of patients with Graves'disease: an evidence-based approach to therapeutic controversies. J Clin Endocrinol Metab 2003; 88: 3474-3481.
81. Surks MI ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 228-238.
82. Weiss RE, Refetoff S. Treatment of resistance to thyroid hormone: primum non nocere. J Clin Endocrinol Metab 1999; 84: 401-404.
83. Svensson J, Ericsson UB, Nilsson P, Olsson C, Jonsson B, Lindberg B, et al. Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditis. J Clin Endocrinol Metab 2006; 91: 1729-1734.
84. Rother KI, Zimmerman D, Schwenk WF. Effect of thyroid hormone treatment on thyromegaly in children and adolescents with Hashimoto disease. J Pediatr 1994; 124: 599-601.
85. Jacobson EM, Tomer Y. The genetic basis of thyroid autoimmunity. Thyroid 2007; 17: 949-961.
86. Jacobson EM, Huber A, Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 2008; 30: 58-62.
87. Smith BR, Sanders J, Furmaniak J. TSH receptor antibodies. Thyroid 2007; 17: 923-938.
88. Botero D, Brown RS. Bioassay of thyrotropin receptor antibodies with Chinese hamster ovary cells transfected with recombinant human thyrotropin receptor: clinical utility in children and adolescents with Graves disease. J Pediatr 1998; 132: 612-618.
89. Brown RS, Cohen JH 3rd, Braverman LE. Successful treatment of massive acute thyroid hormone poisoning with iopanoic acid. J Pediatr 1998; 132: 903-905.
90. Cooper DS. Antithyroid drugs. N Engl J Med 2005; 352: 905-917.
91. Smith J, Brown RS. Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves'disease treated using antithyroid medication. Thyroid 2007; 17: 1103-1107.
92. Lippe BM, Landaw EM, Kaplan SA. Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years. J Clin Endocrinol Metab 1987; 64: 1241-1245.
93. Segni M, Leonardi E, Mazzoncini B, Pucarelli I, Pasquino AM. Special features of Graves'disease in early childhood. Thyroid 1999; 9: 871-877.
94. Rivkees SA, Sklar C, Freemark M. Clinical review 99: The management of Graves'disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 1998; 83: 3767-3776.
95. Zimmerman D, Lteif AN. Thyrotoxicosis in children. Endocrinol Metab Clin North Am 1998; 27: 109-126.
96. Read CH, Jr., Tansey MJ, Menda Y. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves'patients. J Clin Endocrinol Metab 2004; 89: 4229-4233.
97. Sherman J, Thompson GB, Lteif A, Schwenk WF 2nd, van Heerden J, Farley DR, et al. Surgical management of Graves disease in childhood and adolescence: an institutional experience. Surgery 2006; 140: 1056-1061; discussion 61-62.
98. Fisher DA, Klein AH. Thyroid development and disorders of thyroid function in the newborn. N Engl J Med 1981; 304: 702-712.
99. Brown RS, Larson, PR. Thyroid gland development and disease in infancy and childhood. In: Thyroid Disease Manager, 1999: http://thyroidmanager.org